VYCO

$0.05-4.77%visit website

VYCOR MEDICAL INC

Market Cap

$2M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

-0.31

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.9

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	514	417	459	418	1,807
Cost of revenue	62	82	83	74	301
Gross profit	452	335	375	344	1,507
Research & development	0.00	0.00
Selling, general & administrative	405	357	315	323	1,400
Total operating expenses	420	372	329	338	1,459
Operating income	32.1	(36.5)	45.8	6.9	48.2
Pretax income	5.0	(62.4)	20.1	(19.1)	(56.4)
Net income	4.9	(62.7)	20.1	(22.3)	(59.9)
EPS (basic) ($)	0.00		0.00	0.00	0.00
EPS (diluted) ($)	0.00		0.00	0.00	0.00
Weighted avg. shares (basic)	33,373		33,373	33,373
Weighted avg. shares (diluted)	33,373		33,373	33,373

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

4 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 14, 2026 accepted 4:13 PM ET	2.02Earnings release	Document SEC ↗
May 15, 2026 accepted 3:42 PM ET	2.02Earnings release	Document SEC ↗
Mar 31, 2026 accepted 3:31 PM ET	2.02Earnings release	Document SEC ↗
Nov 14, 2025 accepted 11:48 AM ET	2.02Earnings release	Document SEC ↗
Aug 8, 2025 accepted 1:40 PM ET	2.02Earnings release	Document SEC ↗
May 15, 2025 accepted 10:03 AM ET	2.02Earnings release	Document SEC ↗
Apr 15, 2025 accepted 2:24 PM ET	2.02Earnings release	Document SEC ↗